Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 9 EP applications Andrew John Sanderson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 01, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12769787

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 39/39, A61K 9/127, A61K 9/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12738679

LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES

IPC classification:
A61K 39/39, A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12738311

OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

IPC classification:
A61K 39/00, A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12743273

CATIONIC OIL-IN-WATER EMULSIONS

IPC classification:
A61K 47/24, A61K 47/06, A61K 39/00, A61K 9/107
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP14187138

Detoxified Escherichia coli immunogens

IPC classification:
A61K 39/108
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Andrew John Sanderson, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP16184271

VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES

IPC classification:
A61K 9/50, A61K 39/12, A61K 39/00, C12N 15/88, C12N 15/86, A61K 39/245, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16732999

IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/112
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP18157689

OMV VACCINES

IPC classification:
A61K 39/00, C12P 1/04, A61K 39/116, A61K 39/118, C07K 14/295, C12N 1/20
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP18178079

OUTER MEMBRANE VESICLES

IPC classification:
A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature